Effect of plasma glucose on infarct size in focal cerebral ischemia-reperfusion
- PMID: 2046937
- DOI: 10.1212/wnl.41.6.899
Effect of plasma glucose on infarct size in focal cerebral ischemia-reperfusion
Abstract
Although hyperglycemia has been shown to consistently exacerbate ischemia brain injury following global or diffuse cerebral ischemia, the effect of hyperglycemia in unilateral focal cerebral ischemia remains controversial. Recent advances in thrombolytic therapy have enhanced the clinical significance of postischemic reperfusion. We studied the effect of plasma glucose on ischemic brain injury in a newly developed focal cerebral ischemia-reperfusion model. Rats allowed free access to food until ischemic insult developed intra- and postischemic hyperglycemia and cortical infarction. Rats fasted for 24 hours had blunted hyperglycemic responses. Infarct volumes were correspondingly smaller. The protective effect of fasting was partially abolished by glucose loading during ischemia to induce intra-ischemic hyperglycemia. Glucose loading immediately or 3 hours after focal cerebral ischemia did not significantly alter the protective effect of fasting. Insulin treatment in fed rats before ischemia also reduced hyperglycemic responses and infarct volume. Timing of insulin treatment was also critical in the reduction of ischemic injury. These findings indicate that plasma glucose during the period of ischemia is an important determinant of brain injury in focal cerebral ischemia-reperfusion and there is a therapeutic window for normalization of plasma glucose to be efficacious.
Comment in
-
Glucose and infarct size.Neurology. 1991 Dec;41(12):2013. doi: 10.1212/wnl.41.12.2013. Neurology. 1991. PMID: 1745369 No abstract available.
Similar articles
-
Prolongation and enhancement of postischemic c-fos expression after fasting.Stroke. 1997 Feb;28(2):412-8. doi: 10.1161/01.str.28.2.412. Stroke. 1997. PMID: 9040699
-
Coenzyme Q10 ameliorates cerebral ischemia reperfusion injury in hyperglycemic rats.Pathol Res Pract. 2017 Sep;213(9):1191-1199. doi: 10.1016/j.prp.2017.06.005. Epub 2017 Jun 15. Pathol Res Pract. 2017. PMID: 28698101
-
Single-dose ebselen does not afford sustained neuroprotection to rats subjected to severe focal cerebral ischemia.Eur J Pharmacol. 2004 Jul 8;495(1):55-62. doi: 10.1016/j.ejphar.2004.05.024. Eur J Pharmacol. 2004. PMID: 15219820
-
Blood glucose level and morphological brain damage following cerebral ischemia.Cerebrovasc Brain Metab Rev. 1991 Spring;3(1):29-38. Cerebrovasc Brain Metab Rev. 1991. PMID: 2036299 Review.
-
The role of hyperglycemia in acute stroke.Arch Neurol. 2001 Aug;58(8):1209-12. doi: 10.1001/archneur.58.8.1209. Arch Neurol. 2001. PMID: 11493160 Review.
Cited by
-
Uric Acid and Gluconic Acid as Predictors of Hyperglycemia and Cytotoxic Injury after Stroke.Transl Stroke Res. 2021 Apr;12(2):293-302. doi: 10.1007/s12975-020-00862-5. Epub 2020 Oct 17. Transl Stroke Res. 2021. PMID: 33067777 Free PMC article.
-
Neuroprotectants in the Era of Reperfusion Therapy.J Stroke. 2018 May;20(2):197-207. doi: 10.5853/jos.2017.02901. Epub 2018 May 31. J Stroke. 2018. PMID: 29886725 Free PMC article. Review.
-
Uric Acid Is Protective After Cerebral Ischemia/Reperfusion in Hyperglycemic Mice.Transl Stroke Res. 2017 Jun;8(3):294-305. doi: 10.1007/s12975-016-0515-1. Epub 2016 Dec 15. Transl Stroke Res. 2017. PMID: 27981484
-
Drug-Induced Hyperglycemia as a Potential Contributor to Translational Failure of Uncompetitive NMDA Receptor Antagonists.eNeuro. 2021 Dec 29;8(6):ENEURO.0346-21.2021. doi: 10.1523/ENEURO.0346-21.2021. Print 2021 Nov-Dec. eNeuro. 2021. PMID: 34862204 Free PMC article.
-
Retrospective analysis of prognosis and risk factors of patients with stroke by TOAST.Medicine (Baltimore). 2018 Apr;97(15):e0412. doi: 10.1097/MD.0000000000010412. Medicine (Baltimore). 2018. PMID: 29642209 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical